Moneycontrol PRO
HomeAuthorSuchitra mandal

Suchitra Mandal

Moneycontrol.com

LTIM targets $1 billion in incremental revenue post-merger, what do brokerages say?

BUSINESS

LTIM targets $1 billion in incremental revenue post-merger, what do brokerages say?

The company conducted its first analyst meet since the completion of LTI and Mindtree merger in November last year and discussed integration, synergies, growth drivers as well as the impact of the SVB collapse.

Silicon Valley Bank collapse sends midcap tech stocks into the red

BUSINESS

Silicon Valley Bank collapse sends midcap tech stocks into the red

The decline in mid-cap Indian IT stocks Coforge and Mphasis is attributed to their exposure to US regional banks that have been impacted by the collapse of Silicon Valley Bank.

Cipla shares hit 52-week low on reports of I-T probe into tax violations

BUSINESS

Cipla shares hit 52-week low on reports of I-T probe into tax violations

The company’s shares hit a fresh 52-week low after alleged wrongful Tax claims and deductions worth Rs 1,700 crore.

Lemon Tree Hotels jumps 5% after CLSA sees 34% upside

BUSINESS

Lemon Tree Hotels jumps 5% after CLSA sees 34% upside

The company’s share price gained 5 percent after brokerage firm CLSA gave it a target price of Rs 102 per share implying a 34 percent upside potential.

ICICI Lombard gains on RBI nod to stake sale deadline extension

BUSINESS

ICICI Lombard gains on RBI nod to stake sale deadline extension

The share price of ICICI Lombard gained more than 3 percent after RBI approved ICICI Bank’s request to extend deadline for divestment of its stake in ICICI Lombard until September 2024.

L&T, HAL gain on signing supply contracts with defence ministry

BUSINESS

L&T, HAL gain on signing supply contracts with defence ministry

Share prices of HAL and L&T gained after the companies on March 7 signed separate contracts for trainer aircraft and ships with the defence ministry

Analyst Call tracker: Why has Bajaj Auto remained a street favourite this quarter despite export pressures?

BUSINESS

Analyst Call tracker: Why has Bajaj Auto remained a street favourite this quarter despite export pressures?

Despite export challenges faced by Bajaj Auto over the last six months, it saw the highest number of ‘buy’ calls by analysts in the last quarter at 34, up 10 percent. The company’s ‘hold’ calls were down to 13 from 17 a quarter ago.

Analyst Call Tracker: Why is Adani Ports still inspiring confidence among analysts?

BUSINESS

Analyst Call Tracker: Why is Adani Ports still inspiring confidence among analysts?

Despite a strong sell-off of Adani Group stocks, Adani Ports and SEZ made it to the list of top 10 upgrades; it was also the stock on which analysts were most optimistic in the last month as well as quarter.

Alembic Pharma rebounds, up 4% on USFDA nod to Fluorouracil injection

BUSINESS

Alembic Pharma rebounds, up 4% on USFDA nod to Fluorouracil injection

Shares of Alembic Pharma traded higher on Monday after the company received final approval from USFDA for its Fluorouracil Injection 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.

Nykaa shares tumble 2%; Macquarie sees 23% downside in stock

BUSINESS

Nykaa shares tumble 2%; Macquarie sees 23% downside in stock

Nykaa’s share price were down 2 percent on Monday. Brokerage firm Macquarie has initiated coverage on the stock with an ‘underperform’ rating at a target price of Rs 115 per share, implying a downside of 23 percent from current levels. Macquarie’s target price for Nykaa is the lowest among brokerages covering the stock.

Analyst Call Tracker: Why Bajaj Finserv earned street's optimism while HDFC Life faced highest downgrades in February

BUSINESS

Analyst Call Tracker: Why Bajaj Finserv earned street's optimism while HDFC Life faced highest downgrades in February

HDFC Life Insurance was downgraded due to a taxation proposal on high-value insurance policies. Bajaj Finserv drew positive sentiment because of its range of financial services and momentum towards digital transformation.

Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges

BUSINESS

Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges

Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.

MOIL shares edge up on higher production and sales in Feb

BUSINESS

MOIL shares edge up on higher production and sales in Feb

Manganese Ore (India) Limited gained 3 percent after recording 10% YoY jump in production in the month of February.

Analyst Call Tracker: RIL topped the list with max upgrades; Divi’s Lab saw most downgrades in last year

BUSINESS

Analyst Call Tracker: RIL topped the list with max upgrades; Divi’s Lab saw most downgrades in last year

Bajaj Finance, Bajaj Finserv and Adani ports saw the highest upgrades over the past one quarter.

Olectra Greentech jumps 9% on regulatory nod to electric tipper

BUSINESS

Olectra Greentech jumps 9% on regulatory nod to electric tipper

Olectra Greentech has said the first order for 20 e-tippers is in the final stage of discussion and it will also launch variants of the e-tipper and electric truck shortly

Sunteck shares gain after signing lease deal with Upgrad

BUSINESS

Sunteck shares gain after signing lease deal with Upgrad

The company for 29 years has leased 2 lakh square feet of a commercial building in Mumbai to Upgrad, which plans to set up a student housing facility. The project is expected to generate close to Rs 2,000 crore in revenue during the lease tenure

Max Ventures share price rises after NCLT nod to ‘Delhi One’ project

BUSINESS

Max Ventures share price rises after NCLT nod to ‘Delhi One’ project

Max Ventures shares gained 5 percent after subsidiary Max estates received NCLT approval on resolution plan submitted by the company for Boulevard Projects Private Limited.

Mahindra Logistics shares sink 3% as CFO resigns

BUSINESS

Mahindra Logistics shares sink 3% as CFO resigns

Shares traded lower as CFO Yogesh Patel tendered his resignation which will be effective from March 10

Mastek shares rise on strategic alliance with Netail

BUSINESS

Mastek shares rise on strategic alliance with Netail

The strategic partnership will help e-Commerce and Omni-channel retailers optimize their retail value-chain and thereby attract, convert, and retain digital consumers, a company filing said.

Mahindra Lifespace stock falls 5% after CEO Subramanian's resignation

BUSINESS

Mahindra Lifespace stock falls 5% after CEO Subramanian's resignation

The company has named Amit Kumar Sinha as the new MD & CEO. Arvind Subramanian’s resignation will be effective from May 22

Kanoria Chemicals shares up 5% on new plant announcement

BUSINESS

Kanoria Chemicals shares up 5% on new plant announcement

The plant will be set up at the existing facility at GIDC, Ankleshwar in Gujarat and will come with the latest metal oxide-based technology, the company has said.

RateGain stock price rises on partnership with HotelKey

BUSINESS

RateGain stock price rises on partnership with HotelKey

The partnership is expected to integrate RateGain’s global distribution, central reservations and pricing capabilities with HotelKey’s PMS platform

Jefferies turns cautious on chemicals sector on steep valuations, demand headwinds

BUSINESS

Jefferies turns cautious on chemicals sector on steep valuations, demand headwinds

The steep growth expectations have led to a cut in the consensus FY24 estimate despite strong Q3.

PB Fintech shares jump as CEO reiterates profitability target

BUSINESS

PB Fintech shares jump as CEO reiterates profitability target

Shares of PB Fintech rose more than 4 percent on February 22 as CEO Yashish Dahiya reiterated the company's previous expectation of achieving profitability of Rs 1,000 crore by FY26/FY27.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347